Non-ionic surfactant based vesicles (niosomes) in drug delivery
暂无分享,去创建一个
[1] J. Cummings,et al. Adriamycin-loaded niosomes: drug entrapment, stability and release. , 1987, Journal of microencapsulation.
[2] N. Weiner,et al. The effect of dosing volume on the disposition of cyclosporin A in hairless mouse skin after topical application of a non-ionic liposomal formulation: an in vitro diffusion study , 1994 .
[3] A. Schätzlein,et al. TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .
[4] F. Szoka,et al. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[5] I. Uchegbu. Some aspects of the niosomal delivery of doxorubicin. , 1994 .
[6] S. Lesieur,et al. Generation of non-ionic monoalkyl amphiphile-cholesterol vesicles : evidence of membrane impermeability to octyl glucoside , 1996 .
[7] C. Roberts,et al. Antibody responses to Toxoplasma gondii antigen in human peripheral blood lymphocyte‐reconstituted severe‐combined immunodeficient mice reproduce the immunological status of the lymphocyte donor , 1995, European journal of immunology.
[8] G. H. Coombs,et al. Non‐ionic surfactant vesicles, niosomes, as a delivery system for the anti‐leishmanial drug, sodium stibogluconate , 1986, The Journal of pharmacy and pharmacology.
[9] G. Cevc. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. , 1996, Critical reviews in therapeutic drug carrier systems.
[10] A. Florence,et al. The preparation and properties of niosomes—non‐ionic surfactant vesicles , 1985, The Journal of pharmacy and pharmacology.
[11] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[12] J. Double,et al. The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models. , 1996, Journal of drug targeting.
[13] M. Carafa,et al. Vesicles from polysorbate 20 and cholesterol. A simple preparation and a characterization , 1996 .
[14] J. O'grady,et al. The distribution of free and non-ionic vesicular sodium stibogluconate in the dog. , 1993, Journal of drug targeting.
[15] A. Baillie,et al. The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ‐dependent , 1988, The Journal of pharmacy and pharmacology.
[16] Alexander T. Florence,et al. Vesicle (niosome)-in-water-in-oil (v/w/o) emulsions: an in vitro study , 1994 .
[17] A. Polidori,et al. Synthesis of double-chain glycolipids derived from aspartic acid : Preliminary investigation of their colloidal behavior , 1994 .
[18] N. Udupa,et al. Formulation and Evaluation of Oral and Transdermal Preparations of Flurbiprofen and Piroxicam Incorporated with Different Carriers , 1993 .
[19] D. Kerr,et al. Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft. , 1988, British Journal of Cancer.
[20] I. Uchegbu,et al. The evaluation of crown ether based niosomes as cation containing and cation sensitive drug delivery systems , 1997 .
[21] M. Marchand-Arvier,et al. [Hemoglobin niosomes. I. Preparation, functional and physico-chemical properties, and stability]. , 1989, Pharmaceutica Acta Helvetiae.
[22] J. Moreau,et al. Action of octylglucoside on non-ionic monoalkyl amphiphile-cholesterol vesicles: study of the solubilization mechanism , 1990 .
[23] J. Kreuter,et al. Colloidal Drug Delivery Systems , 1994 .
[24] J. Bouwstra,et al. LARGE DISK-SHAPED STRUCTURES (DISCOMES) IN NONIONIC SURFACTANT VESICLE TO MICELLE TRANSITIONS , 1992 .
[25] A. Baillie,et al. Visceral leishmaniasis in the BALB/c mouse: a comparison of the in vivo activity of five non-ionic surfactant vesicle preparations of sodium stibogluconate. , 1995, Journal of drug targeting.
[26] M. Graetzel,et al. Light-induced charge injection in functional crown ether vesicles , 1980 .
[27] H. Junginger,et al. Interactions of non-ionic surfactant vesicles with cultured keratinocytes and human skin in vitro: a survey of toxicological aspects and ultrastructural changes in stratum corneum , 1991 .
[28] N. Udupa,et al. Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in mice. , 1994, Journal of drug targeting.
[29] G. H. Coombs,et al. Vesicular Systems (Niosomes and Liposomes) for Delivery of Sodium Stibogluconate in Experimental Murine Visceral Leishmaniasis , 1988, The Journal of pharmacy and pharmacology.
[30] H. Junginger,et al. Safety Aspects of Non‐ionic Surfactant Vesicles: A Toxicity Study Related to the Physicochemical Characteristics of Non‐ionic Surfactants , 1992, The Journal of pharmacy and pharmacology.
[31] K. Ulbrich,et al. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo , 1989 .
[32] B. Pucci,et al. Vesicles and other supramolecular systems from biocompatible synthetic glycolipids with hydrocarbon and/or fluorocarbon chains. , 1994, Chemistry and physics of lipids.
[33] C. Jain,et al. Preparation and characterization of niosomes containing rifampicin for lung targeting. , 1995, Journal of microencapsulation.
[34] A. Schätzlein,et al. Polyhedral Non‐ionic Surfactant Vesicles , 1997, The Journal of pharmacy and pharmacology.
[35] Minako Tanaka,et al. Properties of the aqueous vesicle dispersion formed with poly(oxyethylene) hydrogenated castor oil , 1990 .
[36] G. Cevc. Electrostatic characterization of liposomes , 1993 .
[37] A. Florence,et al. A non-ionic surfactant vesicle-in-water-in-oil (v/w/o) system: potential uses in drug and vaccine delivery. , 1995, Journal of drug targeting.
[38] R. Duncan,et al. Polymer Conjugates , 1994 .
[39] R. Duncan,et al. Niosomes containing N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin (PK1) : effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution , 1997 .
[40] T. Kunitake,et al. Synthetic bilayer membranes prepared from dialkyl amphiphiles with nonionic and zwitterionic head groups , 1981 .
[41] R. Handjani-Vila,et al. Dispersions of lamellar phases of non‐ionic lipids in cosmetic products , 1979, International journal of cosmetic science.
[42] Robert C. Hider,et al. Liposome formation from synthetic polyhydroxyl lipids. , 1991, Biochimica et biophysica acta.
[43] S. Lesieur,et al. Kinetic aspects of the solubilization of non-ionic monoalkyl amphiphile-cholesterol vesicles by octylglucoside , 1992 .
[44] G Blume,et al. Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.
[45] M. Carafa,et al. Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles , 1998 .
[46] S. Yamada,et al. Application of synthetic alkyl glycoside vesicles as drug carriers. I. Preparation and physical properties. , 1985, Chemical & pharmaceutical bulletin.
[47] J. Brewer,et al. Lipid vesicle‐entrapped influenza A antigen modulates the influenza A‐specific human antibody response in immune reconstituted SCID‐human mice , 1996, European journal of immunology.
[48] M. Carafa,et al. Non-ionic surfactant vesicles as ophthalmic carriers for cyclopentolate. A preliminary evaluation , 1996 .
[49] D. Lasič. On the thermodynamic stability of liposomes , 1990 .
[50] G. Gokel,et al. Aggregation of steroidal lariat ethers: the first example of nonionic liposomes (niosomes) formed from neutral crown ether compounds , 1988 .
[51] I. Uchegbu,et al. Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry , 1995 .
[52] H. Junginger,et al. Niosomes for oral delivery of peptide drugs , 1992 .
[53] J. Bouwstra,et al. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery , 1994 .
[54] C. Cable. An examination of the effect of surface modifications on the physicochemical and biological properties of non-ionic surfactant vesicles , 1990 .
[55] I. Uchegbu. The biodistribution of novel 200-nm palmitoyl muramic acid vesicles , 1998 .
[56] R. New,et al. Liposomes : a practical approach , 1990 .
[57] Vyas Sp,et al. Lymphatic delivery of niosome encapsulated methotrexate. , 1995 .
[58] L. Mayer,et al. Vesicles of variable sizes produced by a rapid extrusion procedure. , 1986, Biochimica et biophysica acta.
[59] B. Pucci,et al. Alkyl and perfluoroalkyl glycolipid-based supramolecular assemblies , 1994 .
[60] H. Junginger,et al. Liposomes and niosomes : interactions with human skin , 1991 .
[61] A. Florence,et al. Non-ionic surfactant based organogels incorporating niosomes , 1996 .
[62] A. Bangham,et al. Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.
[63] N. Udupa,et al. Formulation and Evaluation of Methotrexate Niosomes , 1993 .
[64] A. Schätzlein,et al. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers , 1996 .
[65] H. Junginger,et al. Diffusion of estradiol from non-ionic surfactant vesicles through human stratum corneum in vitro , 1996 .
[66] R. Duncan,et al. Pharmaceutical and biological characterisation of a doxorubicin-polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes , 1997 .
[67] A. Florence,et al. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85) , 1994 .
[68] I. Uchegbu,et al. The Effect of Monomers and of Micellar and Vesicular Forms of Non‐ionic Surfactants (Solulan C24 and Solulan 16) on Caco‐2 Cell Monolayers , 1997, The Journal of pharmacy and pharmacology.
[69] A. Florence,et al. The effect of non‐ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice , 1985, The Journal of pharmacy and pharmacology.
[70] J. Brewer,et al. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. , 1992, Immunology.
[71] H. Kiwada,et al. Tissue distribution and pharmacokinetic evaluation of the targeting efficiency of synthetic alkyl glycoside vesicles. , 1985, Chemical & pharmaceutical bulletin.
[72] J. Cummings,et al. The Distribution of Doxorubicin in Mice Following Administration in Niosomes , 1988, The Journal of pharmacy and pharmacology.
[73] Gregory Gregoriadis,et al. Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes , 1984, Bio/Technology.
[74] D. Crommelin,et al. A novel technique for the one-step preparation of liposomes and nonionic surfactant vesicles without the use of organic solvents. Liposome formation in a continuous gas stream: the 'bubble' method. , 1994, Journal of pharmaceutical sciences.
[75] D. Hoekstra,et al. Vesicle-forming synthetic amphiphiles. , 1995, Biochimica et biophysica acta.
[76] S. Lesieur,et al. Solubilization of Nonionic Monoalkyl Amphiphile−Cholesterol Vesicles by Octyl Glucoside: Cryo-Transmission Electron Microscopy of the Intermediate Structures , 1996 .
[77] G. Trapani,et al. Determination of hydrophile-lipophile balance of some polyethoxylated non-ionic surfactants by reversed-phase thin layer chromatography , 1995 .
[78] J. Double,et al. Drug distribution and a pulmonary adverse effect of intraperitoneally administered doxorubicin niosomes in the mouse , 1994, Biopharmaceutics & drug disposition.
[80] Y. Barenholz,et al. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. , 1993, Biochimica et biophysica acta.
[81] N. Van Rooijen,et al. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.
[82] N. Udupa,et al. Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice. , 1993, Journal of drug targeting.